Harran; Susan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harran; Susan.The latest application filed is for "diazonamide analogs".

Company Profile

0.19.19

Harran; Susan - Dallas TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diazonamide analogs Grant 8,846,734 - Wei , et al. September 30, 2	2014-09-30
Diazonamide Analogs App 20140100193 - Wei; Qi ; et al.	2014-04-10
Dimeric Smac Mimetics App 20130344026 - Sun; Haizhou ; et al.	2013-12-26
Diazonamide analogs Grant 8,592,469 - Wei , et al. November 26, 2	2013-11-26
Small molecule apoptosis promoters Grant 8,586,542 - Hanson , et al. November 19, 2	2013-11-19
Small Molecule Apoptosis Promoters App 20130281385 - Hanson; Gunnar J. ; et al.	2013-10-24
Dimeric Smac mimetics Grant 8,551,955 - Sun , et al. October 8, 2	2013-10-08
Indoline anti-cancer agents Grant 8,334,311 - Hanson , et al. December 18, 2	2012-12-18
Methods for preparing diazonamides Grant 8,299,268 - Hanson , et al. October 30, 2	2012-10-30
Diazonamide Analogs App 20120270841 - Wei; Qi ; et al.	2012-10-25
Indoline Anti-Cancer Agents App 20120264763 - Hanson; Gunnar James ; et al.	2012-10-18
Methods for Preparing Diazonamides App 20120190862 - HANSON; Gunnar ; et al.	2012-07-26
Small molecule apoptosis promoters Grant 8,222,291 - Hanson , et al. July 17, 2	2012-07-17
Small molecule apoptosis promoters App 20120082640 - Hanson; Gunnar J. ; et al.	2012-04-05
Dimeric Smac Mimetics App 20110195043 - Sun; Haizhou ; et al.	2011-08-11
Indoline anti-cancer agents Grant 7,989,482 - Hanson , et al. August 2, 2	2011-08-02
Methods for preparing diazonamides Grant 7,982,051 - Hanson , et al. July 19, 2	2011-07-19
Methods for Preparing Diazonamides App 20110021784 - Hanson; Gunnar ; et al.	2011-01-27
Methods for preparing diazonamides Grant 7,851,620 - Hanson , et al. December 14, 2	2010-12-14
Dimeric pyrrolidine amide-containing small molecule apoptosis promoters Grant 7,807,699 - Hanson , et al. October 5, 2	2010-10-05
Indoline Anti-cancer Agents App 20100035946 - Hanson; Gunnar James ; et al.	2010-02-11
Methods For Preparing Diazonamides App 20090005572 - HANSON; Gunnar ; et al.	2009-01-01
Small molecule apoptosis promoters App 20080051389 - Hanson; Gunnar J. ; et al.	2008-02-28
C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes Grant 7,250,413 - Combrink , et al. July 31, 2	2007-07-31
Rifamycin derivatives effective against drug-resistant microbes Grant 7,247,634 - Ma , et al. July 24, 2	2007-07-24
Rifamycin imino derivatives effective against drug-resistant microbes Grant 7,238,694 - Ding , et al. July 3, 2	2007-07-03
Rifamycin derivatives Grant 7,229,996 - Ma , et al. June 12, 2	2007-06-12
(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions Grant 7,226,931 - Ding , et al. June 5, 2	2007-06-05
Rifamycin derivatives App 20060019985 - Ma; Zhenkun ; et al.	2006-01-26
(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions App 20060019986 - Ding; Charles Z. ; et al.	2006-01-26
Rifamycin derivatives effective against drug-resistant microbes App 20050261262 - Ma, Zhenkun ; et al.	2005-11-24
C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes App 20050256096 - Combrink, Keith ; et al.	2005-11-17
Rifamycin imino derivatives effective against drug-resistant microbes App 20050209210 - Ding, Charles Z. ; et al.	2005-09-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.